
Published On: Oct 2023
Published On: Oct 2023
According to Business Market Insights research, the Asia Pacific non-emergency medical transportation market was valued at US$ 918.84 million in 2022 and is expected to reach US$ 1,607.20 million by 2028 registering a CAGR of 9.8% from 2022 to 2028. Innovations made by companies in India, rising incidence of chronic conditions, and increasing geriatric population are the critical factors attributed to the Asia Pacific non-emergency medical transportation market expansion.
Chronic diseases account for more than 50% of total deaths across the world. As per World Health Organization (WHO) 2021 data, 17.9 million deaths are recorded across the world annually due to cardiovascular diseases, followed by cancers (9.3 million), respiratory diseases (4.1 million), and diabetes (1.5 million). In addition, there has been a staggering rise in the percentage of adults and children affected by chronic illnesses. Apart from worrying about the recurring medical expenses of patients suffering from chronic diseases, family members also need to be proactive in arranging transportation in emergencies, as these patients require regular access to life-saving health services to remain fit. While some might need therapies on daily basis, many visit their physicians for weekly consultations. Moreover, several chronic diseases can result in temporary or permanent immobility. Arranging a separate car may not be possible, especially for families belonging to low-income groups, who do not own any vehicle. In such cases, NEMT proves to be of great help to people. Studies show around 20 million people are suffering from chronic kidney disease who needs to reach the healthcare facilities on time for dialysis. One missed appointment can lead to an emergency admission to the hospital. For such patients, the availability of NEMT is a boon. The easy availability of NEMT offers individuals affected by chronic conditions access to life-sustaining treatments and health care services without delay. NEMT is a reliable way to go to appointments without missing them due to hindrances related to transportation, fuels the growth of the Asia Pacific non-emergency medical transportation market.
On the contrary, compliances and requirements hampers the Asia Pacific non-emergency medical transportation market.
Based on type, the Asia Pacific non-emergency medical transportation market is divided into private pay patient transportation, insurance backed patient transportation, courier services, and other services. The private pay patient transportation segment held 50.7% share of Asia Pacific non-emergency medical transportation market in 2022, amassing US$ 466.05 million. It is projected to garner US$ 832.64 million by 2028 to expand at 10.2% CAGR during 2022–2028.
Based on application, the Asia Pacific non-emergency medical transportation market is segmented into dialysis, routine doctor visits, mental health related appointments, rehabilitation, and others. The mental health related appointments segment held 39.1% share of Asia Pacific non-emergency medical transportation market in 2022, amassing US$ 359.22 million. It is projected to garner US$ 638.09 million by 2028 to expand at 10.0% CAGR during 2022–2028.
Based on country, the Asia Pacific non-emergency medical transportation market is segmented into China, India, Japan, Australia, South Korea, and the Rest of Asia-Pacific. Our regional analysis states that China captured 30.0% share of Asia Pacific non-emergency medical transportation market in 2022. It was assessed at US$ 276.11 million in 2022 and is likely to hit US$ 507.21 million by 2028 exhibiting a CAGR of 10.7% during 2022–2028.
Key players operating, the Asia Pacific non-emergency medical transportation market are Ambulance on Call, Ambulance Private Pty Ltd, Athulya Homes Pvt Ltd, CareFlight Ltd, and GLOBAL RESCUE LLC, among others.
Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com